Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 29 November 2021 – On 5 November 2021, Novo Nordisk initiated a share...
Novo Nordisk announces impact from Volume Based Procurement for insulin in China Bagsværd, Denmark, 26 November 2021 – Novo Nordisk today...
Novo Nordisk A/S – Share repurchase programme Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 22 November 2021 – On 5...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 15 November 2021 – On 5 November 2021, Novo Nordisk initiated a share...
Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency Bagsværd, Denmark, 12 November...
Wegovy™ recommended for approval for the treatment of obesity by the European regulatory authorities Bagsværd, Denmark, 11 November 2021 –...
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021 Bagsværd, Denmark, 8 November 2021 —...
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021 Bagsværd, Denmark, 5 November 2021 —...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 5 November 2021 — As part of the up to DKK 20.0 billion 2021 share...
Novo Nordisk A/S purchases B shares worth DKK 4,109 million from Novo Holdings A/S under the 2021 share repurchase programme Bagsværd...
Trading in Novo Nordisk shares by board members, executives and associated persons on 3 November 2021 Bagsværd, Denmark, 4 November 2021 —...
Novo Nordisk's net profit increased by 12% in the first nine months of 2021 Financial report for the period 1 January 2021 to 30...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 2 November 2021 – On 4 August 2021, Novo Nordisk initiated a share...
Novo Nordisk raises sales and operating profit outlook for 2021 Bagsværd, Denmark, 29 October 2021 – Novo Nordisk today announced that the...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 25 October 2021 – On 4 August 2021, Novo Nordisk initiated a share...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.